Ftse Mib
32.516,70
-3,25%
DAX
17.956,81
-1,68%
S&P 500
5.416,04
-0,33%
NASDAQ
17.635,13
-0,18%
Bitcoin
66.956,32
0,28%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Blueprint Medicines Corporation (BPMC) Blueprint Medicines Corporation (BPMC) Notizie

Blueprint Medicines Corporation

BPMC
104,42
-1,97 (-1,85%)
Ultimo aggiornamento: 16:42:06
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/6/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202423:11EDGAR2Form 144 - Report of proposed sale of securities
05/6/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:40EDGAR2Form 144 - Report of proposed sale of securities
04/6/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202422:28EDGAR2Form 144 - Report of proposed sale of securities
31/5/202422:38EDGAR2Form 144 - Report of proposed sale of securities
31/5/202400:01PRNUSBlueprint Medicines Announces Data Presentations at EAACI..
24/5/202414:00EDGAR2Form 8-K - Current report
23/5/202423:05PRNUSBlueprint Medicines to Present the First Promising and Most..
17/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202423:07EDGAR2Form 144 - Report of proposed sale of securities
15/5/202423:05EDGAR2Form 144 - Report of proposed sale of securities
10/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202423:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202422:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
02/5/202413:00PRNUSBlueprint Medicines Reports Strong First Quarter 2024..
18/4/202414:00PRNUSBlueprint Medicines to Report First Quarter 2024 Financial..
11/4/202414:00PRNUSBlueprint Medicines to Host Webcast and Conference Call..
04/4/202422:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
11/3/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202423:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202423:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
06/3/202416:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:19EDGAR2Form 144 - Report of proposed sale of securities
01/3/202421:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202422:03EDGAR2Form 144 - Report of proposed sale of securities
23/2/202414:00PRNUSBlueprint Medicines Highlights AYVAKIT® (avapritinib)..
22/2/202414:20EDGAR2Form 8-K - Current report
16/2/202422:40EDGAR2Form S-8 - Securities to be offered to employees in employee..
15/2/202423:26EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/2/202413:05EDGAR2Form 8-K - Current report
Apertura: 104,44 Min: 103,49 Max: 106,855
Chiusura: 106,39

La tua Cronologia

NASDAQ
BPMC
Blueprint Medicines
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network